ArticleMolecular therapy. Methods & clinical development2022

A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts.

Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.